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Prevalence of autosomal- Post-transplant recurrence
of focal segmentaldominant polycystic kidney
disease in Alentejo, Portugal glomerulosclerosis
To the Editor: We read with interest the article byTo the Editor: In a recent issue of Kidney International,
Levy and Feingold reviewed studies estimating the prev- Sharma et al, describing the blocking effect of normal
sera on the focal segmental glomerulosclerosis (FSGS)alence of single-gene progressive kidney diseases [1]. We
would also like to report an ongoing study on the preva- activity [1]. Their experiments showed that preincuba-
tion with normal serum followed by washing and subse-lence of autosomal-dominant polycystic kidney disease
(ADPKD) in Alentejo, in the south of Portugal, where quent incubation with FSGS serum resulted in the pro-
tection in permeability effect of FSGS factor(s).a different rate was found. Preliminary data were reported
at the EDTA Congress held in September 1999, in Ma- Posttransplant recurrence of FSGS has been reported
in 30–50% of patients and the outcome is miserable. Todrid, Spain (abstract; de Almeida et al, Nephrol Dial
Transplant 14:A101, 1999). Patients and their families prevent this recurrence we have used plasmapheresis pre-
operatively with satisfactory results. The methods andwere tracked from dialysis centers and nephrology out-
patient services and all nephrologists in the region partic- results have been reported elsewhere [2, 3]. In brief,
ipated. By the prevalence day, July 31, 1999, we identified pretransplant plasmapheresis is repeated 2 to 3 times
84 patients with ADPKD, 16 with renal cysts but with immediately before transplantation and in each session
no family history of renal cysts, and 160 first-degree 50 to 75 mL/kg of the patient’s plasma is exchanged with
relatives with a 50% risk; therefore, a total of 180 af- albumin-Ringer’s solution or fresh-frozen plasma. In our
fected persons were expected. According to the last cen- study, the incidence of recurrence in children with pro-
sus (1991), Alentejo has 543,442 inhabitants, which gave phylactic plasmapheresis was reduced by one half, com-
a prevalence rate of 1:3019. Calculating prevalence rates pared to those who received no prophylaxis. Further-
of monogenic traits based on a priori risk is expected to more, even when recurrence occurred, the degree of
overestimate the true prevalence of the disease. On the proteinuria was markedly less severe.
other hand, underdiagnosis and follow-up by non-nephrol- Focal segmental glomerulosclerosis appears to be the
ogists often underestimates the prevalence. A more accu- immediate consequence of a primary or secondary glo-
rate prevalence is expected when this study is finished and merular epithelial cell defect or injury. In fact, typical
all general practitioners will report on their patients at FSGS lesions appeared later in such patients, as with
that time. persistent proteinuria initiated immediately after trans-
In summary, we present a lower prevalence for ADPKD plantation in our series. Therefore, the first injury by the
than reported by Levy and Feingold [1], a result more so-called FSGS factor(s) may lead to further glomerulo-
consistent with those of Davies et al [2] in the Welsh sclerotic lesions. We speculate that pretransplant plasma-
population. Whether this number is the result of a similar pheresis in our trial may be effective not only in reducing
method or whether it truly represents the prevalence of FSGS factor(s), but also in blocking the effect of FSGS
ADPKD in Alentejo remains to be established. serum with normal serum transfused as substitution fluid.
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